HTG Molecular Diagnostics, Inc. (Formerly Known as High Throughput Genomics, Inc.) Partners With John Wayne Cancer Institute to Commercialize Melanoma Signatures
6/1/2012 9:31:29 AM
More...
|
Nanoliposomes Engineered To Deliver Therapeutic Drugs That Kill Malignant Cells, John Wayne Cancer Institute, Penn State University, And University of Connecticut Study
5/25/2010 7:25:30 AM
More...
|
Tiny Chemotherapy Bubbles Deliver a One-Two Punch to Knock Out Cancer: John Wayne Cancer Institute Scientist Leads Studies of C6-Ceramide Nanoliposomes
5/24/2010 10:18:14 AM
More...
|
HTG Signs Collaboration Agreement with John Wayne Cancer Institute
5/3/2010 9:57:19 AM
More...
|
John Wayne Cancer Institute at Saint John’s Health Center Receives $1 Million Grant from Abraxis BioScience, Inc.
1/12/2010 10:51:18 AM
More...
|
CerRx, Inc. Secures World-Wide Exclusive License from John Wayne Cancer Institute and Children's Hospital Los Angeles on New Formulation of Vitamin A Analog to Treat Cancer
4/30/2009 10:11:14 AM
More...
|
Delcath Systems, Inc. (DCTH) Expands Phase III Trial for Metastatic Melanoma to Include John Wayne Cancer Institute in California
8/12/2008 8:39:56 AM
More...
|
John Wayne Cancer Institute Receives Grant to Study Long-term Health Effects of Traumatic Brain Injuries
7/3/2008 10:04:54 AM
More...
|
DNA Modification Seen in Colorectal Tumors Helps Predict Outcomes, John Wayne Cancer Institute Researchers Find
5/21/2008 9:00:32 AM
More...
|
John Wayne Cancer Institute Researchers Identify Epigenomic Test That Could Improve Treatment for Specific Gastric Cancers
12/11/2007 11:10:31 PM
More...
|
|